AngioDynamics Inc (NASDAQ: ANGO) has reported E.P.S. of $-0.72 for its second fiscal quarter (ending November 30) versus $-0.21 for the same period a year ago. For the latest four quarters through November 30, E.P.S. were $-0.36 compared to $-0.84 a year ago.
Recent Price Action
AngioDynamics Inc (NASDAQ: ANGO) stock closed at $6.21 on 1/5/24 after a major decline of -19.9%. Moreover, exceptionally high trading volume at 465% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months and has declined -22.8% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ANGO is expected to continue to be Value Creation neutral.
AngioDynamics has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. AngioDynamics has a neutral Appreciation Score of 48 but a poor Power Rating of 21, and the Negative Value Trend Rating results.
Rating Review
In light of this new information and highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment